Janssen recruits AI startup to develop blood cancer treatments
The UK startup Intelligent OMICS (Intellomx) has launched a collaboration with Johnson & Johnson’s pharmaceutical company Janssen to use artificial intelligence (AI) to discover drug targets for the treatment of blood cancer.
Robert Grundy Sunitomo Pharma Rolls Royce Janssen Research Development Janssen Research Johnson Innovation
Source: outsourcing-pharma.com